“…1,2,4-Oxadiazole moieties have been used in the design of dipeptidomimetics as peptide building blocks [184a,b]. Compounds 367 contain, at C5 of the 1,2,4-oxadiazole nucleus, a residue of an amino group linked to peptide moieties, and a carboxyl or ester functionality attached at C3 directly or through a methylene chain [293], and 5-HT1D (5-hydroxytryptamine) receptors [294], and as antagonists for 5-HT [295] or histamine H3 receptors [296]. They show activity as antirhinoviral agents [297], growth hormone secretagogues [298], anti-inflammatory agents [234], and antitumor agents [183,188,299].…”